alexa Introducing Miltefosine as an Anti-cryptosporidial Agen
ISSN: 2157-7471

Journal of Plant Pathology & Microbiology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Introducing Miltefosine as an Anti-cryptosporidial Agent in Immunocompromised Mice

Mahmood MN1,2*, Ramadan FN2, Hassan MS2, Sabry HY3 and Magdy MM1

1Biology Department, College of Science for Woman, University of Baghdad, Iraq

2Zoology Department, College of Science, Ain Shams University, Cairo, Egypt

3Parasitology Department, Theodor Bilharz Research Institute, Imbaba 0200, Egypt

4Pathology Department, Theodor Bilharz Research Institute, Imbaba 0200, Egypt

Corresponding Author:
Mahmood MN
Biology Department, College of Science for Woman
University of Baghdad, Al-Jaderia Road, Baghdad, Iraq
Tel: +9647803325625
[email protected]

Received May 18, 2016; Accepted May 30, 2016; Published May 31, 2016

Citation: Mahmood MN, Ramadan FN, Hassan MS, Sabry HY, Magdy MM (2016) Introducing Miltefosine as an Anti-cryptosporidial Agent in Immunocompromised Mice. J Plant Pathol Microbiol 7:354. doi:10.4172/2157-7471.1000354

Copyright: © 2016 Mahmood MN, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Cryptosporidiosis is a clinically significant opportunistic infection causing diarrhea especially among immunocompromised patients includes those with immunodeficiency syndrome and certain immunosuppressed patients undergoing chemotherapy, organ transplant recipients treated with drugs that suppress the immune system, and patients with autoimmune disorders. The aim of this study was to evaluate the potential antiparasitic effect of miltefosine, (a phospholipid drug used for the treatment of visceral and cutaneous leishmaniasis) in immunocompromised (Dexamethasone treated) mice infected with Cryptosporidium. Parasitological examination of feces for oocysts count was performed ten and twenty days after start of treatment. Histopathological examination of intestinal, liver and spleen sections was held. Results revealed no significant reduction in mean Cryptosporidium oocyst number detected in immunocompromised infected group ten days post treatment (1.44%). Twenty days post treatment showed statistical significant reduction (p<0.001) reaching (38.63 %) when compared to the mean oocysts counts of infected untreated immunosuppressed group of mice. Histopathological sections of small intestine, liver and spleen showed several degrees of inflammatory changes before treatment. In treated group with miltefosine no improvements of small intestinal photomicrographs were seen; in contrast, significant improvement was observed in liver and spleen histopathological sections. Ziehl–Neelsen acid-fast stain was originally undertaken for the detection of Cryptosporidium oocysts within intestinal mice tissue. In conclusion, oral administration of miltefosine in vivo showed moderate efficiency against cryptosporidiosis in immunocompromised infected mice.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version